Clinical trial
Steroids and Methotrexate to Treat Systemic Vasculitis
NCT00001256 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00001256 |
|---|---|
| Title | Steroids and Methotrexate to Treat Systemic Vasculitis |
| Official title | An Open Trial of the Efficacy of Glucocorticoids and Methotrexate (MTX) in the Treatment of Systemic Vasculitis |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Inflammation, Vasculitis, Wegener's Granulomatosis |
| Intervention type | Drug |
| Interventions | prednisone and methotrexate |
| Enrollment | 100 |
| Start date | Mar 1, 1990 |
| Completion | Feb 1, 2004 |
| First posted | Nov 4, 1999 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: